BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 20350769)

  • 1. Long-term changes in serum cholesterol level does not influence the progression of coronary calcification.
    Tenenbaum A; Shemesh J; Koren-Morag N; Fisman EZ; Adler Y; Goldenberg I; Tanne D; Hay I; Schwammenthal E; Motro M
    Int J Cardiol; 2011 Jul; 150(2):130-4. PubMed ID: 20350769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated progression of coronary calcification: four-year follow-up in patients with stable coronary artery disease.
    Shemesh J; Koren-Morag N; Apter S; Rozenman J; Kirwan BA; Itzchak Y; Motro M
    Radiology; 2004 Oct; 233(1):201-9. PubMed ID: 15333771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral calcium supplements do not affect the progression of aortic valve calcification or coronary artery calcification.
    Bhakta M; Bruce C; Messika-Zeitoun D; Bielak L; Sheedy PF; Peyser P; Sarano M
    J Am Board Fam Med; 2009; 22(6):610-6. PubMed ID: 19897688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
    Kurnatowska I; Grzelak P; Kaczmarska M; Stefańczyk L; Nowicki M
    Nephron Clin Pract; 2011; 117(4):c297-304. PubMed ID: 20861651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
    Schmermund A; Achenbach S; Budde T; Buziashvili Y; Förster A; Friedrich G; Henein M; Kerkhoff G; Knollmann F; Kukharchuk V; Lahiri A; Leischik R; Moshage W; Schartl M; Siffert W; Steinhagen-Thiessen E; Sinitsyn V; Vogt A; Wiedeking B; Erbel R
    Circulation; 2006 Jan; 113(3):427-37. PubMed ID: 16415377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis.
    Stompór TP; Pasowicz M; Sułowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Konieczyńska M; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2004 Sep; 44(3):517-28. PubMed ID: 15332225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of statin treatment on aortic valve and coronary artery calcification.
    Mohler ER; Wang H; Medenilla E; Scott C
    J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Baumann D; Heuschmid M; Brodoefel H; Claussen CD; Kopp AF; Schroeder S
    Invest Radiol; 2007 Mar; 42(3):189-95. PubMed ID: 17287649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
    Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium concentration of individual coronary calcified plaques as measured by multidetector row computed tomography.
    Moselewski F; O'Donnell CJ; Achenbach S; Ferencik M; Massaro J; Nguyen A; Cury RC; Abbara S; Jang IK; Brady TJ; Hoffmann U
    Circulation; 2005 Jun; 111(24):3236-41. PubMed ID: 15956133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
    Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
    J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis].
    Takahashi T; Hiasa Y; Harada S; Hosokawa S; Kato S; Tanimoto M; Kishi K; Ohtani R
    J Cardiol; 1997 Aug; 30(2):67-72. PubMed ID: 9300286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice.
    Esselstyn CB; Ellis SG; Medendorp SV; Crowe TD
    J Fam Pract; 1995 Dec; 41(6):560-8. PubMed ID: 7500065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
    Raggi P; Davidson M; Callister TQ; Welty FK; Bachmann GA; Hecht H; Rumberger JA
    Circulation; 2005 Jul; 112(4):563-71. PubMed ID: 16009795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.